GeNeuro is developing a new approach to the treatment of diseases associated with human endogenous retrovirus expression with a focus on diseases of the nervous system and autoimmune diseases.
GeNeuro
Scientific Publications
Presentation of Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017
Read more